[1]
R. Devbhandari, “Adverse events following Pfizer-BioNTec vaccine against COVID-19 in population more than 12 years of age, Nepal: Adverse events following Pfizer-BioNTec vaccine”, JPAHS, vol. 9, no. 1, pp. 5–11, Jun. 2022.